Login / Signup

Evaluating circulating cell-free DNA and DNA integrity index as biomarkers in non-small cell lung cancer.

Nada EzzeldinDalia El-LebedyMirhane HassanAlaa Omar ShalabySabah Ahmed Mohamed HusseinAhmed Mohamed GharibGehan HamdyAsmaa Mahmoud MohammedAbeer RamadanMohamed Emam Sobeih
Published in: Journal of the Egyptian National Cancer Institute (2024)
cfDNA and DII represent a promising diagnostic and prognostic tool in NSCLC. This type of noninvasive liquid biopsy revealed its chance in the screening, early diagnosis, and monitoring of NSCLC.
Keyphrases